Thus, in this study, the therapeutic effect of CD47 antisense oligonucleotides (ASO) on obesity and its associated metabolic dysfunction was determined in two obese mouse models (high fat diet induced obesity or genetic obesity models). Here, CD47 is linked to obesity disorder.